申请人:Electrophoretics Limited
公开号:US20160058745A1
公开(公告)日:2016-03-03
The invention relates to pharmaceutical compositions having casein kinase 1 delta (CK1δ) inhibitors and to the use of the inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.